STEM SYNC III, The Hatchery

STEM SYNC III, The Hatchery

Category : News/Events

Interested in a career in biotech innovation and entrepreneurship but don’t know where to start?

Join the folks at the Hatchery for a night of collaborative problem solving (and dinner) as you tackle real world business challenges presented by a panel of Atlanta-based bioentrepreneurs and innovators. This resource is open to All MBA and graduate students (from all 9 schools), regardless of academic concentration.

Featuring:

  • Kiran Pandey, PhD, CEO of Emtherapro
  • Omer Inan, PhD, CSO of Biozen and Cardiosense
  • Yash Vagal, CEO of Curanostics

The event will be held from 5:30 to 7:30pm on Tuesday, January 21st, 2025 at The Hatchery.

Refreshments Provided!

To register, fill out the Google Form linked here.


Log out of this account

Leave a Reply

Upcoming Events

  • EGDRC Seminar: Lynn Aboue-Jaoudé January 14, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/Lynn-Abou-JaoudeEvent Type: Seminar SeriesSeries: Health System Users in Vulnerable Situations: Normative Experiences and “New Ways of Life”Speaker: Lynn Abou-JaoudéContact Name: Wendy GillContact Email: wggill@emory.eduLink: https://tinyurl.com/Lynn-Abou-JaoudeDr. Lynn Abou-Jaoudé studies sociocultural challenges in healthcare experiences, focusing on qualitative research and diabetes prevention at the University of Lille’s LUMEN lab.
  • GCDTR Seminar: Erin Ferranti, PhD, MPH, RN January 21, 2025 at 12:00 pm – 1:00 pm Seminar Series; tinyurl.com… Online Location: https://tinyurl.com/ErinFerrantiEvent Type: Seminar SeriesSeries: Cardiometabolic Risk and Resource Connection in Maternal HealthSpeaker: Erin Ferranti, PhD, MPH, RNContact Name: Wendy GillContact Email: wggill@emory.eduRoom Location: RRR_R809Link: https://tinyurl.com/ErinFerrantiDr. Erin Ferranti, Emory Assistant Professor, researches women’s cardiometabolic disease prevention, health inequities, maternal morbidity, farmworker health, diabetes, and hypertension using biomarkers for early risk identification.

Follow Us on Social Media: